Patents Assigned to United States of America
  • Patent number: 5874749
    Abstract: A device for producing circularly polarized optical emission includes a light emitting semiconductor heterostructure, further including at least one semiconducting layer; a ferromagnetic contact having a magnetic moment, in electrical contact with a layer of the semiconductor heterostructure; and a contact electrically connected to a different region of the semiconductor heterostructure. This light emitting semiconductor heterostructure may be a light emitting diode (LED), or some other structure. The ferromagnetic contact injects spin polarized carriers (electrons or holes) into the semiconducting device, which recombine with their opposing carriers to produce circularly polarized light. A process for producing circularly polarized optical emission includes applying a bias across a light emitting semiconductor heterostructure having a contact with a net magnetic moment, therby injecting spin polarized carriers into the light emitting semiconductor heterostructure.
    Type: Grant
    Filed: June 29, 1993
    Date of Patent: February 23, 1999
    Assignee: The United States of America as represented by the Secretary of the Navy
    Inventor: Berend T. Jonker
  • Patent number: 5874251
    Abstract: Antigens derived from Taenia crassiceps have been isolated which have specificity and sensitivity in their reactivity with antibodies against Taenia saginata and Taenia solium. These antigens may therefor be used in diagnostic testing for the serological screening of livestock for cysticercosis, rather than relying upon methods involving dissection and visual examination.
    Type: Grant
    Filed: May 15, 1996
    Date of Patent: February 23, 1999
    Assignee: The United States of America as represented by the Secretary of Agriculture
    Inventors: Dante Sam Zarlenga, Jr., Marcia Louise Rhoads
  • Patent number: 5874464
    Abstract: Conformationally constrained diacylglycerol analogues, pharmaceutical compositions comprising such analogues, and methods of using such analogues as agonists and antagonists of protein kinase C.
    Type: Grant
    Filed: January 13, 1995
    Date of Patent: February 23, 1999
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Victor E. Marquez, Jeewoo Lee, Rajiv Sharma, Shaomeng Wang, George W. A. Milne, Marc C. Nicklaus, Peter M. Blumberg, Nancy E. Lewin
  • Patent number: 5873500
    Abstract: A cart is provided for delivering fluid to vehicles including aircraft. The fluid can be, e.g., engine oil or hydraulic fluid. The cart has a tank, mounted to a carriage mounted in turn to carrying wheels. The cart has as a dispensing means, a hose ending in a nozzle. Fluid, e.g. oil is added to the tank, followed by an inert gas, e.g., N.sub.2, which pressurizes the tank to about 120 psi. The cart is wheeled to an aircraft and oil delivered to its engines through the dispense means. Such delivery system replaces delivery by quart cans or by mechanical pumps, which have had inefficiency, waste and contaminant drawbacks.
    Type: Grant
    Filed: June 7, 1996
    Date of Patent: February 23, 1999
    Assignee: The United States of America as represented by the Secretary of the Air Force
    Inventors: Richard W. Homburg, Jay A. Murray
  • Patent number: 5873262
    Abstract: In one embodiment, this invention pertains to desalination of seawater by eding methane into seawater at a depth exceeding 100 meters to form methane hydrate which rises to where it is decomposed into methane and water, and recovering water. Methane is recycled.
    Type: Grant
    Filed: June 30, 1997
    Date of Patent: February 23, 1999
    Assignee: The United States of America as represented by the Secretary of the Navy
    Inventors: Michael D. Max, Robert E. Pellenbarg
  • Patent number: 5874221
    Abstract: Phythophthora species which infect potatoes may result in the devastating disease potato late blight or in pink rot. Primers specific for Phythophthora infestans (late blight), and for Phytophthora erythroseptica and Phytophthora nicotianae (pink rot) have been designed which are useful for detecting the presence of the microorganisms by polymerase chain reaction methods. The primers were derived from the internal transcribed spacer region of Phytophthora ribosomal DNA and may be used to confirm the presence of the microorganisms or to distinguish among them.
    Type: Grant
    Filed: August 28, 1996
    Date of Patent: February 23, 1999
    Assignee: The United States of America as represented by the Secretary of Agriculture
    Inventors: Paul Tooley, Britt Bunyard, Marie Carras, Efstathios Hatziloukas
  • Patent number: 5874691
    Abstract: A collapsible training projectile includes a nose, a body and a tail. The dy has a forwardmost end secured to the nose, and a rearwardmost end secured to the tail. The body further includes one or more axial, longitudinal slots that extend radially through at least part of the body, such that when the projectile impacts with an object, the kinetic energy causes the body to plastically deform along the slots, thereby reducing the penetration energy of the projectile. In another embodiment, the projectile includes a wedge, a body and a tail. The forwardmost end of the body is secured to the wedge, and its rearwardmost end is secured to the tail.
    Type: Grant
    Filed: November 21, 1997
    Date of Patent: February 23, 1999
    Assignee: The United States of America as represented by the Secretary of the Navy
    Inventors: Leon Manole, Stewart Gilman, Paul Valenti
  • Patent number: 5874807
    Abstract: The large area plasma processing system (LAPPS) is a system wherein an elron beam is used to produce a plasma. A large area uniform plasma is produced where length and width can be comparable (10's-100's of cm) and very much larger than the plasma thickness (.about.1 cm). The plasma distribution is created independent of the surface to be processed and the bias applied to the surface. The beam-produced plasma has a low intrinsic electron and excitation temperature plasma, allowing the process to be conducted with better control of free radical production. A material, such as a substrate, being processed may be placed in close proximity to plasma with controlled ion bombardment or without substantial bombardment by energetic ions. The system also offers a large available area for gas inflow and removal from the processing chamber and cathode chamber so as not to contaminate the material being processed or damage the cathode.
    Type: Grant
    Filed: August 27, 1997
    Date of Patent: February 23, 1999
    Assignee: The United States of America as represented by the Secretary of the Navy
    Inventors: Robert A. Neger, Richard F. Fensler, Martin Lampe, Wallace Manheimer
  • Patent number: 5875154
    Abstract: An apparatus for producing an acoustic output in an underwater environment ncludes a radiator having a generally elongate, circular x-section with first and second ends, the outer surface of the radiator having a curved shape; an end cap attached to each end of the radiator; and a plurality of piezoceramic elements positioned and arranged to form stacks located exterior to the radiator and between the end caps. The radiator and the end caps seal off the interior of the radiator and provide an air tight cavity interior to the radiator. When a fluctuating voltage is applied across the piezoceramic stacks, the stacks are caused to longitudinally expand and contract in concert with the applied voltage thus inducing a displacement of the end caps. Since the ends of the radiator are attached to the end caps, the radiator is caused to flex inwardly and outwardly as the end caps move longitudinally.
    Type: Grant
    Filed: November 13, 1997
    Date of Patent: February 23, 1999
    Assignee: The United States of America as represented by the Secretary of the Navy
    Inventor: Robert A Dechico
  • Patent number: 5875092
    Abstract: A high energy density electrochemical capacitors with electrodes is formed from proton inserted ruthenium oxides (e.g. HRuO.sub.2.xH.sub.2 O or HRuO.sub.2). The electrode material is formed by reducing ruthenium oxides (e.g. RuO.sub.2.xH.sub.2 O or RuO.sub.2) using electrochemical method or chemical reaction between ruthenium oxides with acetone or methanol. Electrochemical capacitors with electrodes formed of proton inserted ruthenium oxides possess higher energy density, lower resistance, broader operating temperature range, and longer lifetime than that with electrodes comprised ruthenium oxides.
    Type: Grant
    Filed: February 7, 1997
    Date of Patent: February 23, 1999
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: T. Richard Jow, Jian-Ping Zheng
  • Patent number: 5872318
    Abstract: The inventive fatigue-testing apparatus features a compact orbital mechan which rotates a bending force around a non-rotating test section and a stationary test bed. In addition to applying a bending force, some inventive embodiments apply an axial force and a torsional force, thereby accomplishing full-scale evaluation of test sections under three-dimensional loading; the inventive practice for applying bending, torsional and axial loads compares favorably with conventional practice in terms of reliability and cost. The inventive orbital mechanism increases the reliability of the entire inventive test apparatus by reducing the number of moving parts, component wear, maintenance and complexity. The invention also provides maximum access to the test section for instrumentation, inspection, maintenance and modification. The inventive benefits will permit evaluations of larger test sections and will afford extended evaluations to more accurately determine fatigue limitations of complex joints.
    Type: Grant
    Filed: March 14, 1997
    Date of Patent: February 16, 1999
    Assignee: The United States of America as represented by the Secretary of the Navy
    Inventors: Michael A. Troffer, William Minor Appleman, Joseph F. Korczynski, Jr.
  • Patent number: 5872321
    Abstract: An apparatus for conducting impact events for use in conjunction with a hzontal accelerator includes a base having tracks attached to the top thereof; a seat slidably attached to the tracks, the seat capable of moving independently of the base and along the tracks, the seat for positioning a test dummy before and during an impact event; a barrier positioned and arranged adjacent one end of the base for impacting the test dummy, the barrier having load cells for generating signals in response to the impact between the test dummy and the barrier; an attenuator for impacting the seat and accelerating the seat up to the velocity of the base when the base is accelerated by the horizontal accelerator; and an anti-reverse mechanism for retaining the seat after the seat is accelerated up to the velocity of the horizontal accelerator. In operation, a test dummy is positioned on the seat and secured, if desired. The seat is slidably positioned on the base the desired distance from the barrier.
    Type: Grant
    Filed: December 8, 1997
    Date of Patent: February 16, 1999
    Assignee: The United States of America as represented by the Secretary of the Navy
    Inventor: John R. Yannaccone
  • Patent number: 5871962
    Abstract: The nucleotide and deduced amino acid sequences of 51 cDNAs are disclosed where each cDNA encodes the envelope 1 gene of an isolate of hepatitis C virus (HCV). The invention relates to the oligonucleotides, peptides and recombinant envelope 1 proteins derived from these sequences and their use in diagnostic methods and vaccines.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: February 16, 1999
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Jens Bukh, Roger H. Miller, Robert H. Purcell
  • Patent number: 5872210
    Abstract: The present invention describes small, water soluble peptides isolated from a native virus inhibitory sequence that blocks maturation of the virally encoded protease and inhibits the mature protease as well. The peptides may be used in the treatment of virally infected cells, in the preparation of vaccine formulations, in the generation of clinically relevant antibodies and anti-idiotypic antibodies and in the generation of a screening assay or kit that can be used to identify other similarly acting protease inhibitors.
    Type: Grant
    Filed: October 5, 1995
    Date of Patent: February 16, 1999
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventor: John L. Medabalimi
  • Patent number: 5872219
    Abstract: A new substrate of epidermal growth factor receptor and certain other tyrosine kinase receptors denominated eps15, polynucleotides encoding eps15, antisense eps15 polynucleotide, triple helix eps15 polynucleotide, antibodies to eps15, and assays for determining eps15.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: February 16, 1999
    Assignee: The United States of America, as represented by the Department of Health and Human Services
    Inventors: Pier Paolo DiFiore, Francesca Fazioli
  • Patent number: 5872073
    Abstract: New amorphous molybdenum/tungsten sulfides with the general formula M.sup.n+.sub.2x/n (L.sub.6 S.sub.8)S.sub.x, where L is molybdenum or tungsten and M is a ternary metal, has been developed. Characterization of these amorphous materials by chemical and spectroscopic methods (IR, Raman, PES) shows that the (M.sub.6 S.sub.8).sup.0 cluster units are present. Vacuum thermolysis of the amorphous Na.sub.2x (Mo.sub.6 S.sub.8)S.sub.x .multidot.yMeOH first produces poorly crystalline NaMo.sub.6 S.sub.8 by disproportionation at 800.degree. C. and well-crystallized NaMo.sub.6 S.sub.8 at .gtoreq. 900.degree. C. Ion-exchange of the sodium material in methanol with soluble M.sup.2+ and M.sup.3+ salts (M=Sn, Co, Ni, Pb, La, Ho) produces the M.sup.n+.sub.2x/n (Mo.sub.6 S.sub.8)S.sub.x .multidot.yMeOH compounds. Additionally, the new reduced ternary molybdenum sulfides with the general formula M.sup.n+.sub.2x/n Mo.sub.6 S.sub.8+x (MeOH).sub.
    Type: Grant
    Filed: August 9, 1996
    Date of Patent: February 16, 1999
    Assignee: The United States of America as represented by the United States Department of Energy
    Inventors: Shane J. Hilsenbeck, Robert E. McCarley, Glenn L. Schrader, Xiaobing Xie
  • Patent number: 5871998
    Abstract: Recombinant papillomavirus capsid proteins that are capable of self-assembly into capsomer structures and viral capsids that comprise conformational antigenic epitopes are provided. The capsomer structures and viral capsids, consisting of the capsid proteins that are expression products of a bovine, monkey or human papillomavirus L1 conformational coding sequence proteins, can be prepared as vaccines to induce a high-titer neutralizing antibody response in vertebrate animals. The self assembling capsid proteins can also be used as elements of diagnostic immunoassay procedures for papillomavirus infection.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: February 16, 1999
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Douglas R. Lowy, John T. Schiller, Reinhard Kirnbauer
  • Patent number: 5871959
    Abstract: A method of preventing tumor cell metastasis by inhibiting the binding of hepatocyte growth factor/scatter factor ("HGF/SF") with met proto-oncogene protein is described. A method of producing HGF/SF and a cell line for the production of HGF/SF are also described. The met proto-oncogene tyrosine kinase receptor (Met) and its ligand, hepatocyte growth factor/scatter factor (HGF/SF), ordinarily constitute a paracrine signalling system in which cells of mesenchymal origin produce the ligand, which binds to the receptor that is predominantly expressed in cells of epithelial origin. The method of the present invention disrupts the Met-HGF/SF autocrine signaling that contributes to the tumorigenic process in tumors of mesenchymal origin, such as sarcomas.
    Type: Grant
    Filed: November 18, 1994
    Date of Patent: February 16, 1999
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Sing Rong, George Vande Woude, Donna L. Faletto, Ilan Tsarfaty, Marianne Oskarsson
  • Patent number: 5872324
    Abstract: A trimode fuze is provided which comprises a combination of a standard dual ode fuze with the addition of a void sensing mechanism. The modified fuze provides detonation of a warhead under three distinct scenarios: impact upon a hard target with detonation caused by the deformation of the warhead, displacing the hard target firing pin, penetration and continuous deceleration within a solid target with detonation caused by the expiration of a penetration delay timer, and penetration of a soft target with detonation caused by the transition from a target impact deceleration to the lower preset deceleration threshold.The first two modes of detonation are similar to those found in prior art dual mode fuzes. The third mode is brought about when target impact deceleration causes compression of a spring. As the spring compresses, steel balls slide out of a locking mechanism.
    Type: Grant
    Filed: July 7, 1997
    Date of Patent: February 16, 1999
    Assignee: The United States of America as represented by the Secretary of the Navy
    Inventors: Fred W. Watson, Jr, Steve N. Chan
  • Patent number: RE36093
    Abstract: A submersible boat is provided which utilizes a planing boat hull with a sharp bow and blunt stern. The submersible boat performs as a planing boat until it nears the target location. Then, the boat submerges in order to avoid detection. After this vessel submerges, it travels with the blunt end forward and the sharp end aft.
    Type: Grant
    Filed: December 20, 1996
    Date of Patent: February 16, 1999
    Assignee: The United States of America as represented by the Secretary of the Navy
    Inventors: David B. Wyman, JoAnn Davis